Nickel/Cobalt-Catalyzed C(sp<sup>3</sup>)–C(sp<sup>3</sup>) Cross-Coupling of Alkyl Halides with Alkyl Tosylates
作者:Kimihiro Komeyama、Takuya Michiyuki、Itaru Osaka
DOI:10.1021/acscatal.9b03352
日期:2019.10.4
The C(sp3)–C(sp3) cross-coupling of alkyl halides with alkyl tosylates has been developed by employing a combination of nickel and nucleophilic cobalt catalysts in the presence of a manganese reductant. This method provides a straightforward route to a diverse set of not only secondary–primary but also primary–primary C(sp3)–C(sp3) linkages under mild conditions without using alkyl-metallic reagents
The scope of the Giese reaction is expanded using readily available alkyl tosylates as substrates and nucleophilic cobalt(I) catalysts under visible-light irradiation. The reaction proceeds preferentially with less bulky primary alkyl tosylates. This unique reactivity enables the regio-selective Giese reaction of polyol derivatives.
在可见光照射下,使用容易获得的甲苯磺酸烷基酯作为底物和亲核钴 ( I ) 催化剂,扩大了 Giese 反应的范围。该反应优先使用体积较小的伯烷基甲苯磺酸酯进行。这种独特的反应性使多元醇衍生物的区域选择性吉斯反应成为可能。
of alkyl tosylates has been developed by employing a combination of nickel and nucleophilic cobalt catalysts. A single-electron-transfer-type oxidative addition is a pivotal process in the well-established nickel-catalyzed coupling of alkyl halides. However, the method cannot be applied to the homo-coupling of ubiquitous alkyl tosylates due to the high-lying σ*(C–O) orbital of the tosylates. This paper
Reductive amidation of alkyl tosylates with isocyanates by a Ni/Co-dual catalytic system
作者:Takuya Michiyuki、Itaru Osaka、Kimihiro Komeyama
DOI:10.1039/c9cc09377j
日期:——
Reductive amidation of alkyl tosylates with isocyanates using the Ni/Co-dual catalytic system is disclosed. The method proceeds efficiently under mild conditions, giving rise to the corresponding alkyl amides. Notably, the protocol can discriminate the steric environment of two alkyl tosylate moieties, enabling regioselective mono-amidation at the less-bulky site.
Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof; with the proviso that the compound is not Tranilast.